In the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with th...

GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day. GSK's s...